‘Toxic erythema’ and eosinophilia associated with tocilizumab therapy in a COVID‐19 patient

Journal of the European Academy of Dermatology and VenereologyVolume 34, Issue 8 p. e368-e370 Letter to the Editor ‘Toxic erythema’ and eosinophilia associated with tocilizumab therapy in a COVID-19 patient A. Sernicola, A. Sernicola orcid.org/0000-0002-1985-0326 Dermatology Unit, Sapienza University of Rome, Rome, ItalySearch for more papers by this authorG. Carnicelli, G. Carnicelli Dermatology Unit, Sapienza University of Rome, Rome,...